A detailed history of Aptus Capital Advisors, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 11,720 shares of AMRN stock, worth $5,156. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,720
Previous 11,720 -0.0%
Holding current value
$5,156
Previous $8,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$0.63 - $1.07 $269 - $457
-428 Reduced 3.52%
11,720 $8,000
Q1 2024

May 15, 2024

BUY
$0.82 - $1.35 $9,961 - $16,399
12,148 New
12,148 $10,000
Q3 2022

Nov 02, 2022

BUY
$1.09 - $1.67 $18,168 - $27,835
16,668 New
16,668 $18,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.